Lentiviral Vector as a Drug Product- a Gene Therapy Vector Facility Case Study

By | 16 January 2026
  • Introducing Kings College London's Gene Therapy Vector Facility
  • Manufacturing lentiviral vectors as a drug product
  • Highlighting GTVFs CDMO offerings